Private Equity

Updated:

Takeda Ventures

Takeda Ventures runs corporate venture investments in biotechnology and healthcare IT from its Tokyo base.

Takeda Ventures

Takeda Ventures

Takeda Ventures was established in 2018. The firm targets seed through expansion rounds in virtual first care, healthcare IT and medical devices. It has executed co-investments alongside other venture funds in North America and Europe. No headcount or additional offices are recorded. No operational events from the last 24 months appear in available records. The firm functions as the dedicated venture vehicle of Takeda Pharmaceutical, with investment decisions tied to the parent company's strategic priorities in life sciences.

General information

Firm type

Private Equity

Year founded

2018

AUM

Undisclosed

Location

Region

Asia

Country

Japan

City

Tokyo

Corporate office

1-1, Nihonbashi-Honcho 2-chome Chuo-ku, Chuo-ku, Tokyo, Japan

Sector focus

BiotechnologyHealthcare ITPharmaceuticals

Frequently asked questions

Who runs investment decisions at Takeda Ventures?

No named investment committee or principals are disclosed in available records.

Does Takeda Ventures participate in fund commitments or only direct deals?

Available strategy tags list both venture and co-investment activity without specifying fund commitments.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo